Follow The Filings

ALAB Astera Labs Inc.

Information Technology, filed as ASTERA LABS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 3 managers in 2026 Q2, sold by 3

  • 5 Owners
  • Max 6.7%
  • $2.2B
  • 2 new 1 add 1 reduce 2 exits

In 2026 Q2, 2 managers opened positions, 1 added, 1 trimmed, and 2 sold out.

Who owns this now

Largest portfolio weights among holders, up to 6.7% (Glen Kacher, Light Street Capital Management). Not free-float ownership.

  1. Glen Kacher New 6.7%
  2. Alex Sacerdote New 6.1%
  3. Lee Ainslie Add 4.6%
  4. Gavin Baker Reduce 4.1%
  5. Ben Hoskin 0.68%

Who owns ALAB

Sorted by value, long equity only, as of 2026 Q2.

History
Alex Sacerdote, Whale Rock Capital Management 6.1% New 6.1% 1,567,882 $757M History
Gavin Baker, Atreides Management 4.1%, was 7.4% Reduce −63.8% 1,216,795 $588M History
Lee Ainslie, Maverick Capital 4.6%, was 1.2% Add +11.7% 1,067,215 $515M History
Ben Hoskin, Value Aligned Research Advisors 0.68% Hold 568,316 $275M History
Glen Kacher, Light Street Capital Management 6.7% New 6.7% 125,750 $61M History
Estuary Capital Management exited 2026 Q2 Last 2026 Q1 3.1% Exit −3.14% 170,958 $19M History
Spencer Waxman, Shannon River Fund Management exited 2026 Q2 Last 2026 Q1 0.99% Exit −0.99% 47,394 $5.2M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ALAB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ALAB insider trades
  • None no insider bought on the open market
  • $2.4M sold by 1 insider outside a trading plan
  • $620M sold by 7 insiders under 10b5-1 plans
  1. Stefan A Dyckerhoff Director
    Planned sale
    $4.7M 12,499 shares at $376.06
    Traded Oct 7 Filed Oct 9
  2. Stefan A Dyckerhoff Director
    Planned sale
    $3.4M 12,499 shares at $274.96
    Traded Sep 2 Filed Sep 3
  3. Manuel Alba Director
    Planned sale
    $51.3M 183,000 shares at $280.13 42% of stake
    Traded Sep 1 Filed Sep 3
  4. Stefan A Dyckerhoff Director
    Planned sale
    $3.9M 12,499 shares at $311.83
    Traded Aug 6 Filed Aug 10
  5. Manuel Alba Director
    Planned sale
    $3.9M 8,491 shares at $458.38 2.9% of stake
    Traded Jul 1 Filed Jul 6
  6. Manuel Alba Director
    Planned sale
    $16.8M 37,535 shares at $447.39 11% of stake
    Traded Jul 1 Filed Jul 6
  7. Manuel Alba Director
    Planned sale
    $60.5M 136,974 shares at $442.01 9.6% of stake
    Traded Jul 1 Filed Jul 6
  8. Stefan A Dyckerhoff Director
    Planned sale
    $5.6M 12,499 shares at $450.00
    Traded Jul 1 Filed Jul 2
  9. Bethany Mayer Director
    Planned sale
    $271K 686 shares at $395.04 11% of stake
    Traded Jun 24 Filed Jun 26
  10. Jack R Lazar Director
    Planned sale
    $3.6M 10,000 shares at $355.17 12% of stake
    Traded Jun 4 Filed Jun 8
  11. Stefan A Dyckerhoff Director
    Planned sale
    $4.6M 12,499 shares at $364.35
    Traded Jun 3 Filed Jun 5
  12. Sanjay Gajendra COO
    Planned sale
    $116M 400,000 shares at $290.30 7.3% of stake
    Traded May 21 Filed May 26
  13. Philip Mazzara General Counsel and Secretary
    Sale
    $232K 796 shares at $291.03 0.8% of stake
    Traded May 21 Filed May 26
  14. Sanjay Gajendra COO
    Planned sale
    $69.8M 280,000 shares at $249.19 31% of stake
    Traded May 19 Filed May 21
  15. Philip Mazzara General Counsel and Secretary
    Sale
    $2.2M 9,204 shares at $235.36 7.8% of stake
    Traded May 18 Filed May 20

Also filed in the last 12 months, not counted as buying or selling: 143 sales to cover taxes, 19 stock grants, and 6 gifts.

Congress

1 member of Congress traded ALAB in the last three years: 0 buys and 2 sales. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Robert P. Bresnahan, Jr. R-PA-8 Sell $1K–$15K Feb 27, 2025 filed Mar 27, 2025
  2. Robert P. Bresnahan, Jr. R-PA-8 Sell $1K–$15K Feb 18, 2025 filed Mar 10, 2025

SEC filings

Recent issuer filings from EDGAR, 7 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
8-K 5.07
10-Q
8-K 2.02,9.01

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2024 FY2025
Revenue $396.29M $852.52M
Gross profit $302.7M $645.26M
Gross margin * 76.4% 75.7%
Net income -$83.42M $219.13M
Net margin * -21.1% 25.7%

Balance sheet

Metric FY2024 FY2025
Total current assets $1.01B $1.36B
Total non-current assets * $41.53M $169.79M
Total assets $1.05B $1.53B
Total current liabilities $86.54M $133.04M
Total non-current liabilities * $3.17M $35.15M
Total equity $0.965B $1.36B

Cash flow

Metric FY2024 FY2025
Cash from operations $136.68M $319.31M
Cash from investing -$757.57M -$241.47M
Cash from financing $655.84M $9.8M
Net change in cash $34.95M $87.64M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.